Bunge COO exercises options, sells 2,831 shares

Bunge Global’s Chief Operating Officer Julio Garros exercised stock options for 6,500 shares of common stock at an exercise price of $50.07 per share on February 11, 2026.

Rhea-AI Filing Summary

Bunge Global’s Chief Operating Officer Julio Garros exercised stock options for 6,500 shares of common stock at an exercise price of $50.07 per share on February 11, 2026. After the option exercise, he held 130,627.321 common shares directly.

On the same day, Garros sold 2,831 common shares at $119 per share, which the filing states were sold to cover the options’ exercise price. Following this sale, he directly owned 127,796.321 Bunge Global shares.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 3 txns

Insider Garros Julio

Role Chief Operating Officer

Sold 2,831 shs ($337K)

Approx. gross sale proceeds $337K

Approx. exercise cost $325K

Type	Security	Shares	Price	Value
Exercise	Stock Options (Right to buy)	6,500	$0.00	$0.00
Exercise	Common Stock	6,500	$50.07	$325K
Sale	Common Stock	2,831	$119.00	$337K

Holdings After Transaction: Stock Options (Right to buy) — 0 contracts (Direct); Common Stock — 127,796.321 shares (Direct)

Footnotes (2)

1. F1. Represents shares sold to cover the options' exercise price.
2. F2. This option became exercisable in three equal annual installments beginning on March 1, 2017.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Bunge Global (BG) report for Julio Garros?

Julio Garros exercised 6,500 stock options and sold 2,831 shares. He converted options into common stock, then sold a portion of the new shares. The filing notes the sale was to cover the options’ exercise price, leaving him with 127,796.321 shares.

How many Bunge Global (BG) shares does Julio Garros own after this Form 4?

After the reported transactions, Julio Garros directly owns 127,796.321 shares. He first reached 130,627.321 shares following his option exercise, then sold 2,831 shares on the same date, reducing his direct ownership to 127,796.321 shares of Bunge Global common stock.

What was the exercise price of Julio Garros’s Bunge Global (BG) stock options?

The stock options were exercised at an exercise price of $50.07 per share. Garros exercised options covering 6,500 shares of Bunge Global common stock. The filing notes these options became exercisable in three equal annual installments beginning on March 1, 2017.

At what price did Julio Garros sell Bunge Global (BG) shares on February 11, 2026?

He sold 2,831 Bunge Global shares at $119 per share. According to the filing, these shares were sold on February 11, 2026. The explanation section clarifies that the sale was made to cover the exercise price of the stock options he exercised the same day.

Why did Julio Garros sell Bunge Global (BG) shares after exercising options?

The filing states the sale was to cover the options’ exercise price. After exercising 6,500 stock options, Garros sold 2,831 common shares. This sale was specifically described as covering the cost of exercising the options, rather than a standalone discretionary sale.

What type of derivative security did Julio Garros hold in Bunge Global (BG)?

He held stock options giving the right to buy Bunge Global common stock. These options had a $50.07 exercise price and became exercisable in three equal annual installments starting March 1, 2017. After exercising 6,500 options, he no longer held any of these derivatives.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/13/2026 - 05:25 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Garros Julio

(Last) (First) (Middle)

C/O BUNGE GLOBAL SA

1391 TIMBERLAKE MANOR PARKWAY

(Street)

CHESTERFIELD MO 63017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bunge Global SA [ BG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/11/2026		M		6,500	A	$50.07	130,627.321	D
Common Stock	02/11/2026		S		2,831(1)	D	$119	127,796.321	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to buy)	$50.07	02/11/2026		M			6,500	(2)	03/01/2026	Common Stock	6,500	$0	0	D

Explanation of Responses:

1. Represents shares sold to cover the options' exercise price.

2. This option became exercisable in three equal annual installments beginning on March 1, 2017.

Remarks:

	/s/ Drew Yaeger, Attorney-in-Fact	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.